Zenara Pharma launches Paxlovid generic for COVID-19 in India EP News Bureau Sep 12, 2022 The drug reduces the risk of death or hospitalisation by 89 per cent
Zenara Pharma gets CDSCO nod to make and market generic version of Pfizer’s Paxlovid EP News Bureau Jul 28, 2022 The tablet, which will be sold under the brand name ‘Paxzen’, is being manufactured at Zenara’s US FDA approved facility in…
Zenara Pharma, a Biophore subsidiary, gets DCGI nod for favipiravir tablets EP News Bureau Aug 5, 2020 The company informed that these tablets, to be marketed under brand name Favizen, will be manufactured with in-house API